Phrenic nerve stimulation
US-2024173074-A1 · May 30, 2024 · US
US10173069B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10173069-B2 |
| Application number | US-201213586572-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 15, 2012 |
| Priority date | Jan 26, 2012 |
| Publication date | Jan 8, 2019 |
| Grant date | Jan 8, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A fixation device configured to anchor an implantable medical device within a patient includes a temporary biodegradable fixation mechanism configured to secure the device after implantation until the temporary fixation mechanism biodegrades and a chronic fixation mechanism configured to promote tissue growth that secures the device to tissue of the patient before the temporary fixation mechanism biodegrades.
Opening claim text (preview).
The invention claimed is: 1. An implantable medical device (IMD) comprising: a body containing electronics; a fixation device connected to the body of the device, wherein the fixation device comprises: a temporary fixation mechanism comprising a biodegradable material and configured to anchor the IMD within a blood vessel of a patient after implantation until the temporary fixation mechanism biodegrades; and a chronic fixation mechanism overlaying a first side of the body and configured to promote tissue growth along the first side of the body that anchors the IMD within the blood vessel of the patient before the temporary fixation mechanism biodegrades such that the chronic fixation mechanism is configured to more permanently anchor the IMD to the blood vessel than the temporary fixation mechanism, wherein the temporary fixation mechanism is configured to anchor the IMD within the blood vessel such that the first side of the body including the chronic fixation mechanism is arranged against endothelium of the blood vessel, and wherein the chronic fixation mechanism comprises a sheet of tissue growth promoting material configured to be connected to the IMD housing and configured to promote tissue growth into the material to secure the IMD within the blood vessel of the patient before the temporary fixation mechanism biodegrades, wherein the sheet of tissue growth promoting material comprises a rectangular sheet of tissue growth promoting material defined by four edges, and wherein a first edge is attached to the outer surface of the IMD housing and a second edge generally parallel to and offset from the first edge is attached to the outer surface of the IMD housing. 2. The IMD of claim 1 , wherein the temporary fixation mechanism comprises a biodegradable stent configured to be connected to at least one of a first side or a second side of the body of the IMD generally opposite the first side such that the stent is configured to push the first side of the body of the IMD including the chronic fixation mechanism against the endothelium of the blood vessel. 3. The IMD of claim 1 , wherein the blood vessel of the patient comprises at least one of the right or the left first branches of the pulmonary artery, a systemic vessel, a brain vessel, or a renal vessel. 4. The IMD of claim 1 , wherein the temporary fixation mechanism comprises at least one of polyglycolic acid (PGA), poly lactic acid (PLA), polydioxanone (PDS), polyanhydrides, trimethylene carbonate, polyhydroxybutyrate (PHB), polyhydroxyvalerate (PHV), polycaprolactone, polyorthoesters, polyaminoacids, polycyanocrylates, and polyphosphazenes. 5. The IMD of claim 1 , wherein the temporary fixation mechanism comprises a biodegradable material selected from the group consisting of polyesters, polyurethanes, and combinations thereof. 6. The IMD of claim 1 , wherein the temporary fixation mechanism comprises a biodegradable material selected from the group consisting of polyglycolic acid (PGA), polylactic acid (PLA), and combinations thereof. 7. The IMD of claim 1 , wherein the temporary fixation mechanism comprises a biodegradable material selected from the group consisting of magnesium, magnesium alloys, iron, iron alloys, and combinations thereof. 8. The IMD of claim 1 , wherein the temporary fixation mechanism comprises a biodegradable material configured to substantially degrade by a first time sufficient to allow enough tissue growth to the chronic fixation mechanism to secure the IMD within the blood vessel of the patient. 9. The IMD of claim 1 , wherein the sheet of tissue growth promoting material is configured overlay at least part of an outer surface of the body. 10. The IMD of claim 1 , wherein the sheet of tissue growth promoting material comprises a sheet of flexible fabric. 11. The IMD of claim 1 , wherein the first and second edges of the rectangular sheet of tissue growth promoting material are attached to the body of the IMD such that the rectangular sheet of tissue growth promoting material is pulled taut to lay on the outer surface of the body of the IMD. 12. The IMD of claim 1 , wherein the first and second edges of the rectangular sheet of tissue growth promoting material are attached to the body of the IMD such that the rectangular sheet of tissue growth promoting material remains at least partially slack and at least a portion of the rectangular sheet of tissue growth promoting material is offset from the outer surface of the body of the IMD. 13. The IMD of claim 1 , wherein the sheet of tissue growth promoting material is selected from the group consisting of tubular-weave polyethylene velour, polyethylene terephthalate (PET), polytetrafluoroethylene (PTFE) mesh, and combinations thereof. 14. The IMD of claim 1 , wherein the sheet of tissue growth promoting material comprises a sheet of metallic screen. 15. The IMD of claim 14 , wherein the sheet of metallic screen comprises at least one of titanium and stainless steel. 16. The IMD of claim 1 , wherein the electronics include a least one of a battery, a telemetry module, sensing elements and a signal generator configured to generate electrical stimulation. 17. An assembly comprising: an implantable medical device (IMD) comprising a housing containing electronics; and a fixation device for the IMD, the fixation device comprising: a temporary fixation mechanism connected to the IMD, wherein the temporary fixation mechanism comprises a biodegradable material and is configured to anchor the IMD within a blood vessel of a patient after implantation until the temporary fixation mechanism biodegrades; and a chronic fixation mechanism overlaying a first side of the IMD housing, wherein the chronic fixation mechanism is configured to promote tissue growth along the first side of the IMD housing that anchors the IMD within the blood vessel before the temporary fixation mechanism biodegrades such that the chronic fixation mechanism is configured to more permanently anchor the IMD to the blood vessel than the temporary fixation mechanism, wherein the chronic fixation mechanism comprises a sheet of tissue growth promoting material configured to be connected to the IMD housing and configured to promote tissue growth into the material to secure the IMD within the blood vessel of the patient before the temporary fixation mechanism biodegrades, wherein the sheet of tissue growth promoting material comprises a rectangular sheet of tissue growth promoting material defined by four edges, and wherein a first edge is attached to the outer surface of the IMD housing and a second edge generally parallel to and offset from the first edge is attached to the outer surface of the IMD housing, and wherein the temporary fixation mechanism is configured to anchor the IMD within the blood vessel such that the first side of the IMD housing, including the chronic fixation mechanism, is arranged against endothelium of the blood vessel. 18. The assembly of claim 17 , wherein the temporary fixation mechanism comprises a biodegradable stent configured to be connected to at least one of the first side or a second side of the IMD housing such that the stent is configured to push the first side of the IMD housing, including the chronic fixation mechanism, against the endothelium of the blood vessel. 19. The assembly of claim 17 , wherein the blood vessel of the patient comprises at least one of the right or the left branches of the pulmonary artery, a systemic vessel, a brain vessel, or a renal vessel. 20. The assembly of claim 17 , wher
Intravascular implants · CPC title
Stent-grafts · CPC title
made from both resorbable and non-resorbable prosthetic parts, e.g. adjacent parts · CPC title
specially adapted for venous pressure · CPC title
Anchoring of the implants, e.g. fixation · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.